{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:27:13Z","timestamp":1769074033710,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T00:00:00Z","timestamp":1208995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T00:00:00Z","timestamp":1208995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1038\/gt.2008.71","type":"journal-article","created":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T11:37:04Z","timestamp":1209037024000},"page":"870-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects"],"prefix":"10.1038","volume":"15","author":[{"given":"N C","family":"Hasbrouck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K A","family":"High","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,24]]},"reference":[{"key":"BFgt200871_CR1","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1172\/JCI31659","volume":"117","author":"A Deichmann","year":"2007","unstructured":"Deichmann A, Hacein-Bey-Abina S, Schmidt M, Garrigue A, Brugman MH, Hu J et al. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy. J Clin Invest 2007; 117: 2225\u20132232.","journal-title":"J Clin Invest"},{"key":"BFgt200871_CR2","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1172\/JCI31666","volume":"117","author":"A Aiuti","year":"2007","unstructured":"Aiuti A, Cassani B, Andolfi G, Mirolo M, Biasco L, Recchia A et al. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J Clin Invest 2007; 117: 2233\u20132240.","journal-title":"J Clin Invest"},{"key":"BFgt200871_CR3","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1172\/JCI31661","volume":"117","author":"K Schwarzwaelder","year":"2007","unstructured":"Schwarzwaelder K, Howe SJ, Schmidt M, Brugman MH, Deichmann A, Glimm H et al. Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest 2007; 117: 2241\u20132249.","journal-title":"J Clin Invest"},{"key":"BFgt200871_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2796.1997.130135000.x","volume":"241","author":"T Lofqvist","year":"1997","unstructured":"Lofqvist T, Nilsson IM, Berntorp E, Pettersson H . Haemophilia prophylaxis in young patients\u2014a long-term follow-up. J Intern Med 1997; 241: 395\u2013400.","journal-title":"J Intern Med"},{"key":"BFgt200871_CR5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/archpedi.1987.04460110085030","volume":"141","author":"GL Bray","year":"1987","unstructured":"Bray GL, Luban NL . Hemophilia presenting with intracranial hemorrhage. An approach to the infant with intracranial bleeding and coagulopathy. Am J Dis Child 1987; 141: 1215\u20131217.","journal-title":"Am J Dis Child"},{"key":"BFgt200871_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1056\/NEJMoa067659","volume":"357","author":"MJ Manco-Johnson","year":"2007","unstructured":"Manco-Johnson MJ, Abshire TC, Shapiro AD, Riske B, Hacker MR, Kilcoyne R et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535\u2013544.","journal-title":"N Engl J Med"},{"key":"BFgt200871_CR7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood.V73.2.438.438","volume":"73","author":"TD Palmer","year":"1989","unstructured":"Palmer TD, Thompson AR, Miller AD . Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 1989; 73: 438\u2013445.","journal-title":"Blood"},{"key":"BFgt200871_CR8","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1073\/pnas.89.8.3357","volume":"89","author":"SN Yao","year":"1992","unstructured":"Yao SN, Kurachi K . Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc Natl Acad Sci USA 1992; 89: 3357\u20133361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200871_CR9","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1073\/pnas.88.18.8101","volume":"88","author":"SN Yao","year":"1991","unstructured":"Yao SN, Wilson JM, Nabel EG, Kurachi S, Hachiya HL, Kurachi K . Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc Natl Acad Sci USA 1991; 88: 8101\u20138105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt200871_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/73464","volume":"24","author":"MA Kay","year":"2000","unstructured":"Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257\u2013261.","journal-title":"Nat Genet"},{"key":"BFgt200871_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/4743","volume":"5","author":"R Herzog","year":"1999","unstructured":"Herzog R, Yang E, Couto L, Hagstrom J, Elwell D, Fields P et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 5: 56\u201363.","journal-title":"Nat Med"},{"key":"BFgt200871_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 2006; 12: 342\u2013347.","journal-title":"Nat Med"},{"key":"BFgt200871_CR13","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","volume":"101","author":"CS Manno","year":"2003","unstructured":"Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101: 2963\u20132972.","journal-title":"Blood"},{"key":"BFgt200871_CR14","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1089\/104303402760128513","volume":"13","author":"RW Herzog","year":"2002","unstructured":"Herzog RW, Fields PA, Arruda VR, Brubaker JO, Armstrong E, McClintock D et al. Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy. Hum Gene Ther 2002; 13: 1281\u20131291.","journal-title":"Hum Gene Ther"},{"issue":"Suppl","key":"BFgt200871_CR15","first-page":"S233","volume":"11","author":"V Arruda","year":"2005","unstructured":"Arruda V, Stedman HH, Jiang H, Pierce GF, Schuettrumpf J, Furlan Freguia C et al. Correction of hemophilia B phenotype by novel method of regional intravenous delivery of AAV vector to skeletal muscle of hemophilia B dogs. Mol Ther 2005; 11 (Suppl): S233.","journal-title":"Mol Ther"},{"key":"BFgt200871_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1006\/mthe.2001.0442","volume":"4","author":"RW Herzog","year":"2001","unstructured":"Herzog RW, Mount JD, Arruda VR, High KA, Lothrop Jr CD . Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation. Mol Ther 2001; 4: 192\u2013200.","journal-title":"Mol Ther"},{"key":"BFgt200871_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1006\/mthe.2001.0441","volume":"4","author":"PA Fields","year":"2001","unstructured":"Fields PA, Arruda VR, Armstrong E, Chu K, Mingozzi F, Hagstrom JN et al. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9. Mol Ther 2001; 4: 201\u2013210.","journal-title":"Mol Ther"},{"key":"BFgt200871_CR18","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1161\/CIRCULATIONAHA.105.534008","volume":"112","author":"LT Su","year":"2005","unstructured":"Su LT, Gopal K, Wang Z, Yin X, Nelson A, Kozyak BW et al. Uniform scale-independent gene transfer to striated muscle after transvenular extravasation of vector. Circulation 2005; 112: 1780\u20131788.","journal-title":"Circulation"},{"key":"BFgt200871_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/ng0797-270","volume":"16","author":"RO Snyder","year":"1997","unstructured":"Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270\u2013276.","journal-title":"Nat Genet"},{"key":"BFgt200871_CR20","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1182\/blood.V99.8.2670","volume":"99","author":"JD Mount","year":"2002","unstructured":"Mount JD, Herzog RW, Tillson DM, Goodman SA, Robinson N, McCleland ML et al. Sustained phenotype correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 2002; 99: 2670\u20132676.","journal-title":"Blood"},{"key":"BFgt200871_CR21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1172\/JCI200316887","volume":"111","author":"F Mingozzi","year":"2003","unstructured":"Mingozzi F, Liu YL, Dobrzynski E, Kaufhold A, Liu JH, Wang Y et al. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J Clin Invest 2003; 111: 1347\u20131356.","journal-title":"J Clin Invest"},{"key":"BFgt200871_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nm1549","volume":"13","author":"F Mingozzi","year":"2007","unstructured":"Mingozzi F, Maus MV, Hui DJ, Sabatino DE, Murphy SL, Rasko JE et al. CD8(+) T-cell responses to adeno-associated virus capsid in humans. Nat Med 2007; 13: 419\u2013422.","journal-title":"Nat Med"},{"key":"BFgt200871_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/sj.mt.6300090","volume":"15","author":"H Li","year":"2007","unstructured":"Li H, Murphy SL, Giles-Davis W, Edmonson S, Xiang Z, Li Y et al. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes. Mol Ther 2007; 15: 792\u2013800.","journal-title":"Mol Ther"},{"key":"BFgt200871_CR24","doi-asserted-by":"publisher","first-page":"7540","DOI":"10.1128\/JVI.00529-07","volume":"81","author":"C Li","year":"2007","unstructured":"Li C, Hirsch M, Asokan A, Zeithaml B, Ma H, Kafri T et al. Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo. J Virol 2007; 81: 7540\u20137547.","journal-title":"J Virol"},{"key":"BFgt200871_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/hum.2007.001","volume":"18","author":"L Wang","year":"2007","unstructured":"Wang L, Figueredo J, Calcedo R, Lin J, Wilson JM . Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets. Hum Gene Ther 2007; 18: 185\u2013194.","journal-title":"Hum Gene Ther"},{"key":"BFgt200871_CR26","unstructured":"Recombinant DNA Advisory Board NIoH. Recombinant AAV Generation and Purification: Strategies to Reduce Vector Immunogenicity. NIH: Bethesda, MD, 2007, http:\/\/www4.od.nih.gov\/oba\/RAC\/meeting.html."},{"key":"BFgt200871_CR27","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1182\/blood-2006-03-010181","volume":"109","author":"AC Nathwani","year":"2007","unstructured":"Nathwani AC, Gray JT, McIntosh J, Ng CY, Zhou J, Spence Y et al. Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates. Blood 2007; 109: 1414\u20131421.","journal-title":"Blood"},{"key":"BFgt200871_CR28","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","volume":"107","author":"AC Nathwani","year":"2006","unstructured":"Nathwani AC, Gray JT, Ng CY, Zhou J, Spence Y, Waddington SN et al. Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 2006; 107: 2653\u20132661.","journal-title":"Blood"},{"key":"BFgt200871_CR29","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1182\/blood-2007-03-080093","volume":"110","author":"F Mingozzi","year":"2007","unstructured":"Mingozzi F, Hasbrouck NC, Basner-Tschakarjan E, Edmonson SA, Hui DJ, Sabatino DE et al. Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver. Blood 2007; 110: 2334\u20132341.","journal-title":"Blood"},{"key":"BFgt200871_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ymthe.2006.05.004","volume":"14","author":"H Jiang","year":"2006","unstructured":"Jiang H, Pierce GF, Ozelo MC, de Paula EV, Vargas JA, Smith P et al. Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B. Mol Ther 2006; 14: 452\u2013455.","journal-title":"Mol Ther"},{"key":"BFgt200871_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nm1445","volume":"12","author":"LH Vandenberghe","year":"2006","unstructured":"Vandenberghe LH, Wang L, Somanathan S, Zhi Y, Figueredo J, Calcedo R et al. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat Med 2006; 12: 967\u2013971.","journal-title":"Nat Med"},{"key":"BFgt200871_CR32","unstructured":"Recombinant DNA Advisory Board NIoH. Use of Immunosuppression with AAV Vectors. NIH: Bethesda, MD, 2007, http:\/\/www4.od.nih.gov\/oba\/RAC\/meeting.html."},{"key":"BFgt200871_CR33","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","volume":"75","author":"H Nakai","year":"2001","unstructured":"Nakai H, Yant SR, Storm TA, Fuess S, Meuse L, Kay MA . Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol 2001; 75: 6969\u20136976.","journal-title":"J Virol"},{"key":"BFgt200871_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/sj.gt.3301541","volume":"8","author":"A Donsante","year":"2001","unstructured":"Donsante A, Vogler C, Muzyczka N, Crawford JM, Barker J, Flotte T et al. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Therapy 2001; 8: 1343\u20131346.","journal-title":"Gene Therapy"},{"key":"BFgt200871_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.1142658","volume":"317","author":"A Donsante","year":"2007","unstructured":"Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW et al. AAV vector integration sites in mouse hepatocellular carcinoma. Science 2007; 317: 477.","journal-title":"Science"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt200871.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200871","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt200871.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T08:28:29Z","timestamp":1648542509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt200871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,24]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["BFgt200871"],"URL":"https:\/\/doi.org\/10.1038\/gt.2008.71","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,24]]},"assertion":[{"value":"3 March 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}